Sort
40,608 grants matching “prostate cancer”
Microchannel cell-based assays to enable cancer research
$492,306David J Beebe · University Of Wisconsin-Madison · R33 · FY2010 · CA
Mechanism and therapeutic targeting of castration resistance in SPOP-mutated prostate cancer
$492,046Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2025 · CA
Estrogen pathways in the development of prostatic fibrosis and lower urinary tract dysfunction
$492,030William Ricke · University Of Wisconsin-Madison · R01 · FY2024 · DK
Electrical Property Based Image-guided Prostate Biopsy
$492,026Ryan Joseph Halter · Dartmouth College · RC1 · FY2010 · EB
ELUCIDATING THE FUNCTION OF P53-MEDIATED IL17RB REPRESSION
$492,000Yan Zhu · St. John'S University · R15 · FY2024 · CA
Localized SDF-1 mRNA nanoparticle delivery for treating erectile dysfunction.
$491,993Jung Soo Suk · University Of Maryland Baltimore · R01 · FY2025 · DK
Meta-Analysis Systematic and Design Errors: Alcohol Use and Disease Outcomes
$491,984Kaye M Fillmore · Scientific Analysis Corporation · RC1 · FY2010 · AA
Project 2: Investigating cell intrinsic and extrinsic drivers of prostate cancer bone metastasis
$491,936Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2025 · CA
Identification of Natural Compound Combinations for Prevention of Prostate Cancer
$491,916John Digiovanni · University Of Texas At Austin · R01 · FY2023 · CA
Identification of Natural Compound Combinations for Prevention of Prostate Cancer
$491,916John Digiovanni · University Of Texas At Austin · R01 · FY2022 · CA
Rexinoid Synergy in Prostate Cancer Apoptosis
$491,829Marcia I. Dawson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · CA
SENP:Conformational Dynamics and Inhibition by Small Molecules
$491,778Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2014 · GM
Decision Navigation for Advanced Prostate Cancer Treatment Options using mHealth
$491,732Randy Allen Jones · University Of Virginia · R01 · FY2017 · NR
Chemical Probes for Metabolic Pathway Discovery in Human Disease
$491,691Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2014 · CA
DRUG DISCOVERY CORE FACILITY (DDCF)
$491,588Kinfe Ken Redda · Florida Agricultural And Mechanical Univ · G12 · FY2011 · RR
Personalized Immunotherapy of Patients with Ovarian Cancer
$491,531Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
$491,462Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA
Intra-procedure Deformable Ultrasound-MRI Fusion for Prostate Biopsies
$491,366Xenophon Papademetris · Zmk Medical Technologies, D/B/A Eigen · R42 · FY2017 · CA
Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer
$491,293Barbara A Cohn · Public Health Institute · R01 · FY2021 · CA
Tumor Cell Biology Training Program
$491,242Charles F Fox · University Of California Los Angeles · T32 · FY2009 · CA
Rexinoid Synergy in Prostate Cancer Apoptosis
$491,162Marcia I. Dawson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2006 · CA
DRUG DELIVERY CPPs
$491,154Rudolph Juliano · Univ Of North Carolina Chapel Hill · P01 · FY2008 · GM
DIRECT TARGETING OF THE FKBP52 COCHAPERONE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
$491,132The University Of British Columbia · · FY2017 · Department of the Army